Who owns IRONWOOD PHARMACEUTICALS INC?
- CUSIP Number: 46333xah1
Tip: Access positions for across all investors
Analyze quarterly positions in Ironwood Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ironwood Pharmaceuticals stock
Who bought or sold IRONWOOD PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Jpmorgan Chase & Co | 47M | $46M | 100% | Mar 2026 |
|
| Highbridge Capital Management | 47M | $46M | 0% | Mar 2026 |
|
| D. E. Shaw & Co | 29M | $29M | 150% | Mar 2026 |
|
| DeepCurrents Investment Group | 26M | $25M | 0% | Mar 2026 |
|
| Balyasny Asset Management | 18M | $18M | 100% | Mar 2026 |
|
| UBS Group | 2.6M | $2.5M | 100% | Mar 2026 |
|
| Advisory Services Network | 18k | $18k | 0% | Mar 2026 |
|
| Leucadia National Corporation | 13k | $13k | 0% | Mar 2026 |
|
| Steward Partners Investment Advisory | 7.0k | $6.8k | 100% | Mar 2026 |
|
| Brown Trout Management | 7.0k | $6.9M | 75% | Mar 2026 |
|
| Wells Fargo & Company | 5.0k | $4.9k | 0% | Mar 2026 |
|
Who sold out of Ironwood Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Context Capital Management | Mar 2026 | 60M | $58M |
| Braidwell | Dec 2025 | 53M | $51M |
| Advent Capital Management | Dec 2025 | 3.0M | $2.8M |
| Zazove Associates | Mar 2026 | 550k | $522k |